BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35364375)

  • 1. Novel insights into the SPOP E3 ubiquitin ligase: From the regulation of molecular mechanisms to tumorigenesis.
    Li XM; Wu HL; Xia QD; Zhou P; Wang SG; Yu X; Hu J
    Biomed Pharmacother; 2022 May; 149():112882. PubMed ID: 35364375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of Cullin 3 E3 ligases in tumorigenesis.
    Cheng J; Guo J; Wang Z; North BJ; Tao K; Dai X; Wei W
    Biochim Biophys Acta Rev Cancer; 2018 Jan; 1869(1):11-28. PubMed ID: 29128526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of SPOP protein in tumorigenesis and cancer therapy.
    Song Y; Xu Y; Pan C; Yan L; Wang ZW; Zhu X
    Mol Cancer; 2020 Jan; 19(1):2. PubMed ID: 31901237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated activation of the nuclear ubiquitin ligase Cul3-SPOP by the generation of phosphatidylinositol 5-phosphate.
    Bunce MW; Boronenkov IV; Anderson RA
    J Biol Chem; 2008 Mar; 283(13):8678-86. PubMed ID: 18218622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex.
    Kim B; Nam HJ; Pyo KE; Jang MJ; Kim IS; Kim D; Boo K; Lee SH; Yoon JB; Baek SH; Kim JH
    Biochem Biophys Res Commun; 2011 Dec; 415(4):720-6. PubMed ID: 22085717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6.
    Tan Y; Ci Y; Dai X; Wu F; Guo J; Liu D; North BJ; Huo J; Zhang J
    Oncotarget; 2017 Jul; 8(29):47890-47901. PubMed ID: 28599312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin ligase adaptor SPOP in cancer.
    Cuneo MJ; Mittag T
    FEBS J; 2019 Oct; 286(20):3946-3958. PubMed ID: 31495053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase.
    Errington WJ; Khan MQ; Bueler SA; Rubinstein JL; Chakrabartty A; Privé GG
    Structure; 2012 Jul; 20(7):1141-53. PubMed ID: 22632832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase.
    Kwon JE; La M; Oh KH; Oh YM; Kim GR; Seol JH; Baek SH; Chiba T; Tanaka K; Bang OS; Joe CO; Chung CH
    J Biol Chem; 2006 May; 281(18):12664-72. PubMed ID: 16524876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-α protein turnover.
    Zhang P; Gao K; Jin X; Ma J; Peng J; Wumaier R; Tang Y; Zhang Y; An J; Yan Q; Dong Y; Huang H; Yu L; Wang C
    Cell Death Dis; 2015 Mar; 6(3):e1687. PubMed ID: 25766326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions.
    Jiang Q; Zheng N; Bu L; Zhang X; Zhang X; Wu Y; Su Y; Wang L; Zhang X; Ren S; Dai X; Wu D; Xie W; Wei W; Zhu Y; Guo J
    Mol Cancer; 2021 Aug; 20(1):100. PubMed ID: 34353330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPOP in Cancer: Phenomena, Mechanisms and Its Role in Therapeutic Implications.
    Yang X; Zhu Q
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.
    Wu F; Dai X; Gan W; Wan L; Li M; Mitsiades N; Wei W; Ding Q; Zhang J
    Cancer Lett; 2017 Jan; 385():207-214. PubMed ID: 27780719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cullin 3 and Its Role in Tumorigenesis.
    Chen RH
    Adv Exp Med Biol; 2020; 1217():187-210. PubMed ID: 31898229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of high-order oligomerization of the cullin-3 adaptor SPOP.
    van Geersdaele LK; Stead MA; Harrison CM; Carr SB; Close HJ; Rosbrook GO; Connell SD; Wright SC
    Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1677-84. PubMed ID: 23999291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1.
    Li C; Ao J; Fu J; Lee DF; Xu J; Lonard D; O'Malley BW
    Oncogene; 2011 Oct; 30(42):4350-64. PubMed ID: 21577200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher-order oligomerization promotes localization of SPOP to liquid nuclear speckles.
    Marzahn MR; Marada S; Lee J; Nourse A; Kenrick S; Zhao H; Ben-Nissan G; Kolaitis RM; Peters JL; Pounds S; Errington WJ; Privé GG; Taylor JP; Sharon M; Schuck P; Ogden SK; Mittag T
    EMBO J; 2016 Jun; 35(12):1254-75. PubMed ID: 27220849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Ser/Thr-rich degrons mediate the degradation of Ci/Gli by the Cul3-HIB/SPOP E3 ubiquitin ligase.
    Zhang Q; Shi Q; Chen Y; Yue T; Li S; Wang B; Jiang J
    Proc Natl Acad Sci U S A; 2009 Dec; 106(50):21191-6. PubMed ID: 19955409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments.
    Bouchard JJ; Otero JH; Scott DC; Szulc E; Martin EW; Sabri N; Granata D; Marzahn MR; Lindorff-Larsen K; Salvatella X; Schulman BA; Mittag T
    Mol Cell; 2018 Oct; 72(1):19-36.e8. PubMed ID: 30244836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G3BP1 inhibits Cul3
    Mukhopadhyay C; Yang C; Xu L; Liu D; Wang Y; Huang D; Deonarine LD; Cyrta J; Davicioni E; Sboner A; Robinson BD; Chinnaiyan AM; Rubin MA; Barbieri CE; Zhou P
    Nat Commun; 2021 Nov; 12(1):6662. PubMed ID: 34795264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.